SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-088046
Filing Date
2023-03-31
Accepted
2023-03-31 16:12:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d448803ddefa14a.htm DEFA14A 17414
2 GRAPHIC g448803g0331231941650.jpg GRAPHIC 4556
  Complete submission text file 0001193125-23-088046.txt   24792
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36352 | Film No.: 23787771
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences